Henning et al. (2022) report development of a novel class of agents, bivalent deubiquitinase (DUB)-targeting chimeras (DUBTACs), that can selectively stabilize protein targets. These findings encourage further pursuit of targeted protein stabilization as a new paradigm in chemical biology and drug discovery.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.molcel.2022.03.039 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!